Psoriasis: bases genéticas y patogenéticas

Asumalahti, 2003, Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis, J Invest Dermatol, 120, 627, 10.1046/j.1523-1747.2003.12094.x Gudjonsson, 2003, Psoriasis patients who are homozygous for the HLA-Cw*0602 allele have a 2.5-fold increased risk of developing psoriasis compared with Cw6 heterozygotes, Br J Dermatol, 148, 233, 10.1046/j.1365-2133.2003.05115.x Bowcock, 2004, The genetics of psoriasis, psoriatic arthritis and atopic dermatitis, Hum Mol Genet, 13, R43, 10.1093/hmg/ddh094 Nickoloff, 2007, Immunopathogenesis of psoriasis, Clin Rev Allergy Immunol, 33, 45, 10.1007/s12016-007-0039-2 Lowes, 2007, Pathogenesis and therapy of psoriasis, Nature, 445, 866, 10.1038/nature05663 Buchau, 2007, Innate immunity and antimicrobial defense systems in psoriasis, Clin Dermatol, 25, 616, 10.1016/j.clindermatol.2007.08.016 Ellis, 1986, Cyclosporine improves psoriasis in a double-blind study, JAMA, 256, 3110, 10.1001/jama.1986.03380220076026 Gottlieb, 1995, Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis, Nat Med, 1, 442, 10.1038/nm0595-442 Gottlieb, 2000, Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study, J Am Acad Dermatol, 43, 595, 10.1067/mjd.2000.107945 Abrams, 2000, Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells, J Exp Med, 192, 681, 10.1084/jem.192.5.681 Kircik, 2009, Anti-TNF agents for the treatment of psoriasis, J Drugs Dermatol, 8, 546 Benson, 2011, Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab, Nat Biotechnol, 29, 615, 10.1038/nbt.1903 Boyman, 2004, Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha, J Exp Med, 199, 731, 10.1084/jem.20031482 Conrad, 2007, Alpha1 beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis, Nat Med, 13, 836, 10.1038/nm1605 Steinman, 2007, A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage, Nat Med, 13, 139, 10.1038/nm1551 Kryczek, 2008, Induction of memory IL-17+ T cell trafficking and expansion by IFN-gamma: mechanism and pathological relevance, J Immunol, 181, 4733, 10.4049/jimmunol.181.7.4733 Nograles, 2009, IL-22-producing «T22» T cells account for upregulated IL22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells, J Allergy Clin Immunol, 123, 1244, 10.1016/j.jaci.2009.03.041 Capon, 2004, An update on the genetics of psoriasis, Dermatol Clin, 22, 339, 10.1016/S0733-8635(03)00125-6 Valdimarsson, 2004, Psoriasis: a complex clinical and genetic disorder, Curr Rheumatol Rep, 6, 314, 10.1007/s11926-004-0044-x Allen, 2005, The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis, J Invest Dermatol, 124, 103, 10.1111/j.0022-202X.2004.23511.x Valdimarsson, 2007, The genetic basis of psoriasis, Clin Dermatol, 25, 563, 10.1016/j.clindermatol.2007.08.010 Sun, 2008, Follow-up analysis of 180 Chinese Han families: identification of a novel locus for psoriasis at 2p22.3-11.2, Br J Dermatol, 158, 512, 10.1111/j.1365-2133.2007.08417.x Nair, 2006, Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene, Am J Hum Genet, 78, 827, 10.1086/503821 Fan, 2008, Fine mapping of the psoriasis susceptibility locus PSORS1 supports HLA-C as the susceptibility gene in the Han Chinese population, PLoS Genet, 4, e1000038, 10.1371/journal.pgen.1000038 Duffin, 2009, Genetic variations in cytokines and cytokine receptors associated with psoriasis found by genome-wide association, J Invest Dermatol, 129, 827, 10.1038/jid.2008.308 Elder, 2010, Molecular dissection of psoriasis: integrating genetics and biology, J Invest Dermatol, 130, 1213, 10.1038/jid.2009.319 Cargill, 2007, A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes, Am J Hum Genet, 80, 273, 10.1086/511051 Nair, 2009, Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways, Nat Genet, 41, 199, 10.1038/ng.311 Capon, 2007, Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis, Hum Genet, 122, 201, 10.1007/s00439-007-0397-0 Smith, 2008, Polymorphisms in the IL-12beta and IL-23R genes are associated with psoriasis of early onset in a UK cohort, J Invest Dermatol, 128, 1325, 10.1038/sj.jid.5701140 Nair, 2008, Polymorphisms of the IL12B and IL23R genes are associated with psoriasis, J Invest Dermatol, 128, 1653, 10.1038/sj.jid.5701255 Huffmeier, 2009, Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis, J Invest Dermatol, 129, 355, 10.1038/jid.2008.233 Bowes, 2010, The genetics of psoriatic arthritis: lessons from genome-wide association studies, Discov Med, 10, 177 Liu, 2008, A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci, PLoS Genet, 4, e1000041, 10.1371/journal.pgen.1000041 Zhang, 2009, Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21, Nat Genet, 41, 205, 10.1038/ng.310 Bowes, 2010, Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritis, Ann Rheum Dis, 69, 2199, 10.1136/ard.2010.130575 Huffmeier, 2010, Deletion of LCE3C and LCE3B genes at PSORS4 does not contribute to susceptibility to psoriatic arthritis in German patients, Ann Rheum Dis, 69, 876, 10.1136/ard.2009.108951 Zheng, 2011, Variants in MHC, LCE and IL12B have epistatic effects on psoriasis risk in Chinese population, J Dermatol Sci, 61, 124, 10.1016/j.jdermsci.2010.12.001 Xu, 2011, Deletion of LCE3C and LCE3B genes is associated with psoriasis in a northern Chinese population, Br J Dermatol, 165, 882, 10.1111/j.1365-2133.2011.10485.x Duffin, 2009, Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking, J Invest Dermatol, 129, 2777, 10.1038/jid.2009.169 Ellinghaus, 2010, Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2, Nat Genet, 42, 991, 10.1038/ng.689 Hüffmeier, 2010, Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis, Nat Genet, 42, 996, 10.1038/ng.688 Gudjonsson, 2009, Current understanding of the genetic basis of psoriasis, Expert Rev Clin Immunol, 5, 433, 10.1586/eci.09.13 Nair, 2009, Psoriasis bench to bedside: genetics meets immunology, Arch Dermatol, 145, 462, 10.1001/archdermatol.2009.73 Duffin, 2010, Genetic variations associated with psoriasis and psoriatic arthritis found by genome-wide association, Dermatol Ther, 23, 101, 10.1111/j.1529-8019.2010.01303.x Capon, 2008, Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene, Hum Mol Genet, 17, 1938, 10.1093/hmg/ddn091 Li, 2009, Further genetic evidence for three psoriasis-risk genes: ADAM33, CDKAL1, and PTPN22, J Invest Dermatol, 129, 629, 10.1038/jid.2008.297 Wolf, 2008, Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease, J Med Genet, 45, 114, 10.1136/jmg.2007.053595 Quaranta, 2009, Differential contribution of CDKAL1 variants to psoriasis, Genes Immun, 10, 654, 10.1038/gene.2009.51 Strange, 2010, A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1, Nat Genet, 42, 985, 10.1038/ng.694 Bijlmakers, 2011, Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis, Hum Mol Genet, 20, 3129, 10.1093/hmg/ddr215 Sun, 2010, Association analyses identify six new psoriasis susceptibility loci in the Chinese population, Nat Genet, 42, 1005, 10.1038/ng.690 Stuart, 2010, Genome-wide association analysis identifies three psoriasis susceptibility loci, Nat Genet, 42, 1000, 10.1038/ng.693 Prinz, 2001, Psoriasis vulgaris--a sterile antibacterial skin reaction mediated by cross-reactive T cells? An immunological view of the pathophysiology of psoriasis, Clin Exp Dermatol, 26, 326, 10.1046/j.1365-2230.2001.00831.x Feng, 2009, Multiple loci within the major histocompatibility complex confer risk of psoriasis, PLoS Genet, 5, e1000606, 10.1371/journal.pgen.1000606 Pollock, 2011, Differential major histocompatibility complex class I chain-related A allele associations with skin and joint manifestations of psoriatic disease, Tissue Antigens, 77, 554, 10.1111/j.1399-0039.2011.01670.x Mallon, 2000, HLA-C and guttate psoriasis, Br J Dermatol, 143, 1177, 10.1046/j.1365-2133.2000.03885.x Baker, 2006, Peptidoglycan and peptidoglycan-specific Th1 cells in psoriatic skin lesions, J Pathol, 209, 174, 10.1002/path.1954 Gudjonsson, 2004, Immunopathogenic mechanisms in psoriasis, Clin Exp Immunol, 135, 1, 10.1111/j.1365-2249.2004.02310.x Hollox, 2008, Psoriasis is associated with increased beta-defensin genomic copy number, Nat Genet, 40, 23, 10.1038/ng.2007.48 Suzuki, 2004, Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris, J Invest Dermatol, 122, 1133, 10.1111/j.0022-202X.2004.22517.x Holm, 2005, Distinct HLA-C/KIR genotype profile associates with guttate psoriasis, J Invest Dermatol, 125, 721, 10.1111/j.0022-202X.2005.23879.x Williams, 2005, Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis, Hum Immunol, 66, 836, 10.1016/j.humimm.2005.04.005 Płoski, 2006, A role for KIR gene variants other than KIR2DS1 in conferring susceptibility to psoriasis, Hum Immunol, 67, 521, 10.1016/j.humimm.2006.04.001 Chang, 2007, Cytokine gene polymorphisms in Chinese patients with psoriasis, Br J Dermatol, 156, 899, 10.1111/j.1365-2133.2007.07820.x Lippens, 2011, Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis, Cell Death Differ, 18, 1845, 10.1038/cdd.2011.55 Matmati, 2011, A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis, Nat Genet, 43, 908, 10.1038/ng.874 Martin, 2011, A20 edits ubiquitin and autoimmune paradigms, Nat Genet, 43, 822, 10.1038/ng.916 Kool, 2011, The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity, Immunity, 35, 82, 10.1016/j.immuni.2011.05.013 Harrington, 2005, Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages, Nat Immunol, 6, 1123, 10.1038/ni1254 Newcomb, 2011, Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production, J Allergy Clin Immunol, 127, 1006, 10.1016/j.jaci.2010.11.043 Marrakchi, 2011, Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis, N Engl J Med, 365, 620, 10.1056/NEJMoa1013068 Onoufriadis, 2011, Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis, Am J Hum Genet, 89, 432, 10.1016/j.ajhg.2011.07.022 Cowen, 2012, DIRA, DITRA, and new insights into pathways of skin inflammation: what's in a name?, Arch Dermatol, 148, 381, 10.1001/archdermatol.2011.3014 Jordan, 2012, PSORS2 is due to mutations in CARD14, Am J Hum Genet, 90, 784, 10.1016/j.ajhg.2012.03.012 Jordan, 2012, Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis, Am J Hum Genet, 90, 796, 10.1016/j.ajhg.2012.03.013